Skip to main content

Peer Review reports

From: Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach

Original Submission
23 Feb 2021 Submitted Original manuscript
3 Mar 2021 Author responded Author comments - Jung Won Chun
Resubmission - Version 2
3 Mar 2021 Submitted Manuscript version 2
15 Mar 2021 Reviewed Reviewer Report
3 Apr 2021 Reviewed Reviewer Report
15 Apr 2021 Author responded Author comments - Jung Won Chun
Resubmission - Version 3
15 Apr 2021 Submitted Manuscript version 3
22 Apr 2021 Author responded Author comments - Jung Won Chun
Resubmission - Version 4
22 Apr 2021 Submitted Manuscript version 4
Publishing
29 Apr 2021 Editorially accepted
11 May 2021 Article published 10.1186/s12885-021-08277-7

You can find further information about peer review here.

Back to article page